-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Achieve Life Sciences (ACHV)
-
-
-
-
-
-
-
Achieve Life Sciences presents 52-week cytisinicline safety data
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences (ACHV)
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Achieve Life Sciences (ACHV)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences (ACHV)
-
-
-
-
-
-
-
Achieve Life Sciences (ACHV) Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation
-
-
-
-
-
-
-
Achieve Life Sciences (ACHV) Appoints Mark Oki as Chief Financial Officer
-
479,040 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


